Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
202.31
-2.54 (-1.24%)
Mar 4, 2026, 4:00 PM EST - Market closed
Universal Health Services Stock Forecast
Stock Price Forecast
The 12 analysts that cover Universal Health Services stock have a consensus rating of "Buy" and an average price target of $230.25, which forecasts a 13.81% increase in the stock price over the next year. The lowest target is $185 and the highest is $302.
Price Target: $230.25 (+13.81%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Universal Health Services stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 7 | 7 | 7 | 8 | 8 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 12 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $235 → $212 | Hold | Maintains | $235 → $212 | +4.79% | Mar 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $250 → $229 | Hold | Maintains | $250 → $229 | +13.19% | Feb 27, 2026 |
| Barclays | Barclays | Buy Maintains $262 → $268 | Buy | Maintains | $262 → $268 | +32.47% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $263 → $262 | Buy | Maintains | $263 → $262 | +29.50% | Jan 22, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $251 → $245 | Strong Buy | Maintains | $251 → $245 | +21.10% | Jan 7, 2026 |
Financial Forecast
Revenue This Year
18.61B
from 17.36B
Increased by 7.15%
Revenue Next Year
19.50B
from 18.61B
Increased by 4.78%
EPS This Year
23.86
from 23.10
Increased by 3.27%
EPS Next Year
25.99
from 23.86
Increased by 8.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 19.6B | 20.9B | ||
| Avg | 18.6B | 19.5B | ||
| Low | 17.5B | 18.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 13.0% | 12.1% | ||
| Avg | 7.2% | 4.8% | ||
| Low | 0.9% | -3.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 25.94 | 29.44 | ||
| Avg | 23.86 | 25.99 | ||
| Low | 22.02 | 23.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 12.3% | 23.4% | ||
| Avg | 3.3% | 8.9% | ||
| Low | -4.7% | -2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.